Literature DB >> 28430331

Factors Influencing Intravitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema.

Tai K Kim1, Hye Y Shin1, Su Y Kim1, Young C Lee1, Mee Y Lee1.   

Abstract

PURPOSE: To evaluate factors associated with response to intravitreal bevacizumab (IVB) and intravitreal triamcinolone acetonide (IVTA) in diabetic macular edema (DME).
METHODS: Ninety-one eyes of 88 patients diagnosed with DME were enrolled in this retrospective chart review. Group 1 included eyes that showed good response to IVB. Group 2 included eyes that did not respond to IVB but responded to IVTA. Group 3 included eyes that responded to neither. Clinical factors, HbA1c, and optical coherence tomography (OCT) findings including patterns of macular edema were compared among the 3 groups.
RESULTS: A total of 44, 27, and 20 eyes were included in groups 1, 2, and 3, respectively. HbA1c was higher in group 3 than in the other groups. Proportion of full (combination of all patterns) type edema was higher in group 3 than in the other 2 groups. In group 1, the proportion of sponge-like diffuse retinal thickening type was higher and cystoid macular edema type was lower than in the other groups.
CONCLUSIONS: The degree of diabetic control and morphologic subtypes with OCT should be considered to better predict the prognosis after treatment in DME.

Entities:  

Keywords:  Bevacizumab; HbA1c; Macular edema; Triamcinolone; VEGF

Mesh:

Substances:

Year:  2017        PMID: 28430331     DOI: 10.5301/ejo.5000974

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  5 in total

1.  Outcome of intravitreal Avastin® injections in patients with macular oedema in Uganda: a cohort study.

Authors:  Rachel R Kabunga; John Onyango; Sam Ruvuma; Simon Arunga
Journal:  Eye (Lond)       Date:  2022-05       Impact factor: 4.456

2.  Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases.

Authors:  Yen-Po Chen; Ai-Ling Wu; Chih-Chun Chuang; San-Ni Chen
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

3.  Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study.

Authors:  Patricia Udaondo; Cristina Hernández; Laura Briansó-Llort; Salvador García-Delpech; Olga Simó-Servat; Rafael Simó
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

Review 4.  Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography.

Authors:  Yoo-Ri Chung; Young Ho Kim; Seong Jung Ha; Hye-Eun Byeon; Chung-Hyun Cho; Jeong Hun Kim; Kihwang Lee
Journal:  J Diabetes Res       Date:  2019-12-20       Impact factor: 4.011

5.  Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema.

Authors:  Ayumi Usui-Ouchi; Asaka Tamaki; Yoshihito Sakanishi; Kazunori Tamaki; Keitaro Mashimo; Toshiro Sakuma; Nobuyuki Ebihara
Journal:  Life (Basel)       Date:  2021-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.